Back to Selection     Print       Date : 31 Jul 2026
Fund Summary
Nippon India Pharma Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 05-Jun-04
Corpus(Cr.) 9044.0 Latest NAV 567.3404 As on 11-09-2026
Equity(%) 97.32 52 Week High 581.042
Debt(%) 2.68 52 Week Low 481.825
Others(%) 0.0 Exit Load 1% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.51
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Sailesh Raj Bhan
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 38.41%
Top 10 Holdings 57.34%
Top 25 Holdings 89.47%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 73.51
Healthcare 21.12
Retail 2.69
Cash 2.68
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.55
PE Ratio 38.70
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Ltd. 13.31
Lupin Ltd 7.25
Divis Laboratories Ltd. 6.52
Cipla Ltd. 6.03
Apollo Hospitals Enterprises Ltd. 5.30
Dr. Reddys Laboratories Ltd. 5.01
Mankind Pharma Limited 3.74
Sai Life Sciences Limited 3.62
Ajanta Pharma Ltd. 3.41
Max Healthcare Institute Limited 3.15
Medplus Health Services Limited 2.69
GlaxoSmithkline Pharmaceuticals Ltd. 2.66
Ipca Laboratories Ltd. 2.57
Thyrocare Technologies Limited 2.51
Vijaya Diagnostic Centre Limited 2.42
Abbott India Ltd. 2.24
Triparty Repo 2.16
Gland Pharma Limited 2.16
PIRAMAL PHARMA LIMITED 2.09
Dr. Lal Pathlabs Limited 2.05
Alkem Laboratories Limited 2.01
Narayana Hrudayalaya Limited 1.80
Pfizer Ltd. 1.65
Emcure Pharmaceuticals Limited 1.58
Aurobindo Pharma Ltd. 1.54

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-1.24% 5.34% 10.76% 9.34%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
-4.06% -0.40% -0.20% -5.82%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
-0.53% 6.28% 11.24% 12.39%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
3.71% 17.54% 12.61% 14.73%
 
 
-2.88% 6.63% 7.39% 11.72%
 
 
6.44% 19.99% 13.31% 10.77%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Nippon India Pharma Fund (G) 14.76% 0.9512 10.6963% 45.5902 0.1359
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Nippon India Pharma Fund (G) 13.2820% 0.0002 0.2661 14.6406 1.0434
 
Back to Selection